Galmed Pharmaceuticals Ltd.
- GLMD
- NASDAQ
- Biotechnology
- Liver Disease Biotech (NASH)
$4.63
Today +21.05%Quote Sep 9, 2026, 08:00 PM UTC
−19.95%over the last month
Max drawdown −26.3%From 1-month high −25.5%3 months −24.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$4.8M
Quote Sep 9
Next earnings
Nov 25
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$4.48
3.1% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about GLMDPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
6
Founded
2000